Mofema’s strategic goal is to become one of the leading providers of the state-of-the-art eCTG solutions for monitoring of the fetal well-being using artificial intelligence.
The company wants to achieve its goal by the following activities:
registration of the PregnaLIFE24 system elements on key markets,
providing the market with a telemedicine system that will monitor fetal well-being in real time, using proprietary algorithms,
establishing cooperation with strategic industry partners (telemedicine platforms with an international reach and companies offering fetal monitoring solutions).